Home / Tag Archives: prostate cancer drugs

Tag Archives: prostate cancer drugs

Pfizer to Buy Medivation for $14 Billion

August 2016 WallStreet; Pfizer Inc. said Monday that it had agreed to buy biotech Medivation Inc. for about $14 billion, in a move that adds one of the crown jewels of the multibillion-dollar market for cancer drugs to Pfizer’s portfolio. The agreement ends months of bidding for San Francisco’s Medivation, …

Read More »